Valuation: Inogen, Inc.

Market Cap 192M 173M 160M 145M 270M 18.32B 273M 1.91B 760M 9.59B 722M 707M 30.44B P/E 2026 *
-9.48x
P/E 2027 * -15.3x
Enterprise Value 192M 173M 160M 145M 270M 18.32B 273M 1.91B 760M 9.59B 722M 707M 30.44B EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.52x
Free-Float
87.05%
Yield 2026 *
-
Yield 2027 * -
1 day+1.68%
1 week+8.70%
Current month+37.57%
1 month+33.27%
3 months+12.93%
6 months-1.36%
Current year+7.89%
1 week 6.94
Extreme 6.94
7.3
1 month 5.26
Extreme 5.265
7.3
Current year 5.04
Extreme 5.045
7.67
1 year 5.04
Extreme 5.045
8.55
3 years 4.37
Extreme 4.37
13.33
5 years 4.13
Extreme 4.13
40.49
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 09/11/2023
Director of Finance/CFO 48 05/04/2026
Chief Operating Officer 56 05/07/2026
Director TitleAgeSince
Director/Board Member 66 05/08/2014
Chairman 65 28/12/2021
Director/Board Member 59 21/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Controller/Auditor

1,500 0.0057%
01/09/26 Free

General Counsel

46,443 0.1750%
01/09/26 Free

Chief Executive Officer

1,500 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+1.68%+8.70%-15.01%+72.21% 192M
-0.45%+2.12%-18.93%+10.54% 178B
+0.86%+2.15%-19.13%+16.07% 117B
+0.88%+1.88%+1.66%+36.51% 116B
-2.26%+2.24%-44.03%+5.76% 91.03B
-0.31%-4.72%-3.36%+72.86% 61.89B
-0.32%-0.19%+10.38%+83.80% 55.85B
+0.07%+0.42%+5.94%-22.43% 53.16B
+0.30%+1.70%-11.26%+43.83% 44.35B
+0.10%+3.08%-3.06%-8.71% 33.59B
Average +0.05%+1.72%-9.68%+31.04% 75.03B
Weighted average by Cap. -0.13%+1.25%-12.43%+24.22%

Financials

2026 *2027 *
Net sales 356M 320M 296M 268M 500M 33.94B 506M 3.53B 1.41B 17.76B 1.34B 1.31B 56.39B 373M 334M 309M 280M 523M 35.49B 529M 3.7B 1.47B 18.57B 1.4B 1.37B 58.95B
Net income -20.8M -18.66M -17.25M -15.63M -29.19M -1.98B -29.55M -206M -82.17M -1.04B -78.05M -76.41M -3.29B -13.35M -11.98M -11.07M -10.03M -18.74M -1.27B -18.96M -132M -52.74M -665M -50.1M -49.04M -2.11B
Net Debt - -
Projected Income Statement - Annual - Inogen, Inc.
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
28/10/26 US$7.250 +1.68% 281,212
27/10/26 US$7.130 +0.71% 199,611
26/10/26 US$7.080 -0.28% 191,801
23/10/26 US$7.100 +0.85% 239,253
22/10/26 US$7.040 +5.55% 514,176
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - Inogen, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.250USD
Average target price
12.00USD
Spread / Average Target
+65.52%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Inogen, Inc.
  1. Stock Market
  2. Stocks
  3. INGN Stock